0 129

Cited 23 times in

Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.

Authors
Koh, YW; Lee, HJ; Ahn, JH; Lee, JW; Gong, G
Citation
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(10):9823-9830, 2014
Journal Title
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
ISSN
1010-42831423-0380
Abstract
The aim of this study was to determine the predictive or prognostic impact of absolute neutrophil count/absolute lymphocyte count ratio (NLR) in breast cancer patients with estrogen receptor/progesterone receptor (ER/PR)-positive and human epidermal growth factor receptor 2 (HER2)-negative subtype who have received neoadjuvant chemotherapy (NAC). We performed retrospective analysis of 157 patients with primary breast cancer with ER/PR-positive and HER2-negative subtype who were treated with NAC, followed by definitive surgical resection. The median follow-up after surgery was 21 months (range, 1-108 months). On univariate analysis, high NLR (>2.25) correlated with poorer recurrence-free survival (RFS) and overall survival (OS) (P = 0.001 and P < 0.001). Subgroup analysis of non-pathologic complete response (pCR) subgroup showed that high NLR was significant for RFS and OS (P = 0.001 and P < 0.001). Particularly, high NLR patients had inferior clinical outcomes in the high clinical stage. Uni- and multivariate Cox analysis showed NLR to be an only predictor of RFS and OS. The NLR is an independent prognostic factor for RFS and OS in breast cancer patients with ER/PR-positive and HER2-negative subtype receiving NAC. The NLR provides additional prognostic information to choose suitable patients who might profit from further therapy.
MeSH terms
AdultAgedBreast Neoplasms/immunologyBreast Neoplasms/mortalityBreast Neoplasms/pathologyChemotherapy, AdjuvantFemaleHumansImmunohistochemistryKaplan-Meier EstimateLymphocyte CountLymphocytes/immunologyMiddle AgedNeoadjuvant TherapyNeutrophils/immunologyPrognosisProportional Hazards ModelsReceptor, ErbB-2/biosynthesisReceptors, Estrogen/biosynthesisReceptors, Progesterone/biosynthesisRetrospective StudiesYoung Adult
DOI
10.1007/s13277-014-2282-5
PMID
24986572
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
AJOU Authors
고, 영화
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse